You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

 

5182 Results
Symptom Management
Symptom Management
Guidelines and Advice
Status: Current
Version: 1
Nov 2024
Drug
Other Name(s): Tecentriq™
Quick Link(s): Drug Monograph, Patient Info Sheet
Mar 2024
Drug
Other Name(s): Avastin® , Mvasi®; Zirabev®; Bambevi®; Abevmy®; Aybintio®; Vegzelma™
Quick Link(s): Drug Monograph, Patient Info Sheet
Nov 2024
Drug
Other Name(s): Erbitux®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jul 2023
Drug
Other Name(s): Imfinzi®
Quick Link(s): Drug Monograph, Patient Info Sheet
Dec 1969
Drug
Other Name(s): Sarclisa®
Quick Link(s): Drug Monograph, Patient Info Sheet
Dec 1969
Drug
Other Name(s): Opdivo®
Quick Link(s): Drug Monograph, Patient Info Sheet
Oct 2024
Drug
Other Name(s): Abraxane®
Quick Link(s): Drug Monograph, Patient Info Sheet
Dec 1969
Drug
Other Name(s): Inrebic®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jan 2025
Regimen
Cancer Type:
Gastrointestinal, 
Colorectal, 
Small bowel and appendix
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Panitumumab - In Combination with Chemotherapy for Metastatic Colorectal, Small Bowel, or Appendiceal Cancer
New Drug Funding Program
    Panitumumab - First-Line Treatment for Left-Sided Metastatic Colorectal Cancer
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
PANitumumab,
oxaliplatin,
leucovorin,
fluorouracil
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jan 2025

Pages